BDBM50091451 (E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(6-hydroxy-1H-indol-3-yl)-piperidin-1-yl]-pentyl}-acrylamide::CHEMBL51332::TCMDC-139282
SMILES: Oc1ccc2c(c[nH]c2c1)C1CCN(CCCCCNC(=O)\C=C\c2ccc(Cl)c(Cl)c2)CC1
InChI Key: InChIKey=DNYSOLPQKMHVCF-WEVVVXLNSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50091451 ((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(6-hydroxy-1H-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 360 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity against C-C chemokine receptor type 2 | Bioorg Med Chem Lett 10: 1803-6 (2000) BindingDB Entry DOI: 10.7270/Q2H70F2Z | |||||||||||
More data for this Ligand-Target Pair |